Biotechnology, Animal Biotechnology, Genome Informatics and Cancer Biology were established. Dr. Fuller W. Bazer was Director from 1994 to 2001. Under the Bazer administration by agreement between the Texas A&M University President Ray Bowen and The University of Texas Health Science Center at Houston President Dr. David Low, the University of Texas' Institute of Molecular Medicine for Prevention of Human Disease (Hans Muller-Eberhard, Director) was established on two floors of the IBT building. During this period similar cooperative efforts between Texas A&M University and The University of Texas Health Science Center at Houston resulted in acceptance of IBT Texas A&M faculty into the UT Graduate School of Biomedical Sciences. The building became a hub for the Texas GigaPop and similar high speed, broad bandwidth internet activities of the Texas A&M University's Academy for Advanced Telecommunications and Distance Learning. In 1997 the IBT became a college level unit of the newly established Texas A&M Health Science Center. Dr. Richard Finnell served as director 2001-2005 under whose leadership the Texas Institute for Genomic Medicine (TIGM) was established. Dr. Robert Schwartz served as director for 2006–2009. In 2007 a self-study called for a strategic plan in which the IBT would be the founding basic research element of a broader Texas A&M Health Science Center Houston Campus representing all components of the Health Science Center in Houston. Dr. David Carlson, the Texas A&M Health Science Center Vice President of Research and Graduate Studies served as the interim IBT Director 2009–2011. In 2011 Dr. Cheryl Lyn Walker was appointed as the current Director of IBT. Organizational structure Under its college level status within the Texas A&M Health Science Center, the IBT consists of thematic Centers (departments) led by a Center Director and tenured and tenure-track faculty, research track faculty and associate and adjunct faculty. The approximately $10 million operating budget of the IBT consists of about 30% state funds, 50% federal grants and 20% private sources. Current Centers include Cancer and Stem Cell Biology (formerly Cancer Biology and Nutrition), Epigenetics and Disease Prevention, Environmental and Genetic Medicine, Infectious and Inflammatory Diseases (formerly Extracellular matrix Biology) and Translational Cancer Research. The IBT Graduate Program consists of students from the Texas A&M Health Science Center Graduate School of Biomedical Sciences, other Texas A&M System programs, The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences and other programs in Texas Medical Center institutions